Early evidence of this vulnerability, which showed a pronounced reliance on PARP when HR pathways were compromised, shifted the focus of researchers in the broader DDR field to investigate whether similar liabilities exist in other malignancies, including for PCa [39]. Here, PARP1 is linked to posterior cortical atrophy.